GSK 621659A
| CAS No. | 475489-15-7 | Cat. No. | BCP25985 |
| Name | GSK 621659A | ||
| Synonyms | NVP-ADW742;ADW-742; | ||
| Formula | C28H31N5O | M. Wt | 453.58 |
| Description | GSK 552602A is a novel small weight molecular inhibitor of IGF-IR with potential anticancer activity. NVP-ADW742 inhibited IGF-IR-mediated proliferation with an IC50 of 11.12 µmol/l. NVP-ADW742 induced early suppression of Akt, P38 and GSK-3β phosphorylation. NVP-ADW742 enhanced the chemosensitivity of Daoy to temozolomide in vitro, as a potent anti-tumor agent highly selective against IGF-IR. NVP-ADW742 was found to suppresse survival and resistance to chemotherapy in acute myeloid leukemia cells. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | IGF1R | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.